BioMarin Pharmaceutical Inc. buy Bank of America Co.
Start price
17.09.24
/
50%
€62.80
Target price
17.09.25
€103.34
Performance (%)
-26.54%
End price
18.09.25
€46.13
Summary
This prediction ended on 18.09.25 with a price of €46.13. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -26.54%. Bank_of_America_Co_ has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 2.361% | 2.361% | -12.636% |
| iShares Core DAX® | 4.852% | -4.418% | 13.097% |
| iShares Nasdaq 100 | 3.999% | -3.283% | 31.335% |
| iShares Nikkei 225® | 4.221% | -6.223% | 44.472% |
| iShares S&P 500 | 3.324% | -3.174% | 24.360% |
Comments by Bank_of_America_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Bank of America Co. from $130.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.12
11.03.26
11.03.26
€73.15
11.03.27
11.03.27
-7.67%
02.04.26
02.04.26
Stopped prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€98.56
20.02.26
20.02.26
-21.69%
21.02.26
21.02.26